Anti-ERK5 antibody [R07-9G1] (STJA0036146)

SPECIFICATIONS
ClonalityMonoclonal
HostRabbit
ConjugationUnconjugated
IsotypeIgG
ImmunogenA synthesized peptide derived from human ERK5
STJA0036146
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRabbit monoclonal anti-ERK5 for use in WB, ICC, IF, IP and FC in Human, Mouse and Rat samples. Datasheet included with dilution recommendations, and related reagents.
ApplicationsWB/ICC/IF/IP/FC
HostRabbit
ReactivityHuman/Mouse/Rat
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ClonalityMonoclonal
Clone IDR07-9G1
IsotypeIgG
ConjugationUnconjugated
PurificationAffinity Chromatography
Dilution RangeWB 1:500-1:1000
IF 1:50-1:200
IP 1:50
FC 1:50-1:100
FormulationRabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
Storage InstructionStore at 4°C short term. Aliquot and store at-20°C long term. Avoid freeze/thaw cycles.

Target Information

Gene SymbolMAPK7
Gene ID5598
Uniprot IDMK07_HUMAN
ImmunogenA synthesized peptide derived from human ERK5

Additional Info

Tissue Specificity Expressed in many adult tissues. Abundant in heart, placenta, lung, kidney and skeletal muscle. Not detectable in liver.
Post Translational Modifications Dually phosphorylated on Thr-219 and Tyr-221, which activates the enzyme. Autophosphorylated in vitro on threonine and tyrosine residues when the C-terminal part of the kinase, which could have a regulatory role, is absent.
Function Plays a role in various cellular processes such as proliferation, differentiation and cell survival. The upstream activator of MAPK7 is the MAPK kinase MAP2K5. Upon activation, it translocates to the nucleus and phosphorylates various downstream targets including MEF2C. EGF activates MAPK7 through a Ras-independent and MAP2K5-dependent pathway. As part of the MAPK/ERK signaling pathway, acts as a negative regulator of apoptosis in cardiomyocytes via interaction with STUB1/CHIP and promotion of STUB1-mediated ubiquitination and degradation of ICER-type isoforms of CREM. May have a role in muscle cell differentiation. May be important for endothelial function and maintenance of blood vessel integrity. MAP2K5 and MAPK7 interact specifically with one another and not with MEK1/ERK1 or MEK2/ERK2 pathways. Phosphorylates SGK1 at Ser-78 and this is required for growth factor-induced cell cycle progression. Involved in the regulation of p53/TP53 by disrupting the PML-MDM2 interaction.
Protein Name Mitogen-Activated Protein Kinase 7
Map Kinase 7
Mapk 7
Big Map Kinase 1
Bmk-1
Extracellular Signal-Regulated Kinase 5
Erk-5
Database Links Reactome: R-HSA-198753
Reactome: R-HSA-198765
Reactome: R-HSA-202670
Reactome: R-HSA-2559582
Reactome: R-HSA-881907
Reactome: R-HSA-8853659
Cellular Localisation Cytoplasm
Nucleus
Pml Body
Translocates To The Nucleus Upon Activation
Alternative Antibody Names Anti-Mitogen-Activated Protein Kinase 7 antibody
Anti-Map Kinase 7 antibody
Anti-Mapk 7 antibody
Anti-Big Map Kinase 1 antibody
Anti-Bmk-1 antibody
Anti-Extracellular Signal-Regulated Kinase 5 antibody
Anti-Erk-5 antibody
Anti-MAPK7 antibody
Anti-BMK1 antibody
Anti-ERK5 antibody
Anti-PRKM7 antibody

Information sourced from Uniprot.org

Citations

Product Review